The Cancer Vaccine That Could Save Moderna
- Forfatter
- Afsnit
- 932
- Udgivet
- 28. aug. 2026
- Forlag
- 0 Anmeldelser
- 0
- Afsnit
- 932 of 300
- Længde
- 23M
- Sprog
- Engelsk
- Format
- Kategori
- Økonomi & Business
For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ’s Xavier Martinez traces Moderna’s wild ride from scrappy startup to the frontier of cancer treatment. Ryan Knutson hosts.
Further Listening:
- The FDA Commissioner on Vaccines and Public Trust
- The Creator of the Record-Setting Covid Vaccine
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Other podcasts you might like ...
- The Can Do WayTheCanDoWay
- HW News Business Tit-BitsHW News Network
- 1,5 graderAndreas Bäckäng
- Self-Compassionate ProfessorPhD
- Networth and Chill with Your Rich BFFVivian Tu
- Don't Be SourMaxx Chewning
- Mark My Words PodcastMark Homer
- EGO NetCastMartin Lindeskog
- The Pathless Path with Paul MillerdPaul Millerd
- SvD LedarredaktionenSvenska Dagbladet
- The Can Do WayTheCanDoWay
- HW News Business Tit-BitsHW News Network
- 1,5 graderAndreas Bäckäng
- Self-Compassionate ProfessorPhD
- Networth and Chill with Your Rich BFFVivian Tu
- Don't Be SourMaxx Chewning
- Mark My Words PodcastMark Homer
- EGO NetCastMartin Lindeskog
- The Pathless Path with Paul MillerdPaul Millerd
- SvD LedarredaktionenSvenska Dagbladet
